Long-term survival and fate of the leg in de novo intermittent claudication

European Heart Journal - Quality of Care and Clinical Outcomes

Volumn 3, Issue 3, 2017, Pages 208-215

  Kumakura, Hisao ^a   Kanai, Hiroyoshi ^a   Hojo, Yoshiaki ^a   Iwasaki, Toshiya ^a   Ichikawa, Shuichi ^a  

^a Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital)   (Japan)

Author keywords

Critical limb ischaemia; Intermittent claudication; Life expectancy; Peripheral arterial disease; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BERAPROST; C REACTIVE PROTEIN; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SARPOGRELATE; TICLOPIDINE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DISEASE COURSE; DRUG USE; FEMALE; FEMOROPOPLITEAL BYPASS; HEMODIALYSIS; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LEG REVASCULARIZATION; LIFE EXPECTANCY; LONG TERM SURVIVAL; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; EPIDEMIOLOGY; FOLLOW UP; FORECASTING; JAPAN; LEG; RISK FACTOR; SURVIVAL RATE; TRENDS; VASCULAR SURGERY; VASCULARIZATION;

AGED; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INTERMITTENT CLAUDICATION; JAPAN; LEG; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VASCULAR SURGICAL PROCEDURES;

EID: 85041679923     PISSN: 20585225     EISSN: 20581742     Source Type: Journal    
DOI: 10.1093/ehjqcco/qcw057     Document Type: Article

References (32)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-S67.
2. Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 2008;52:1736-1742.
3. Kumakura H, Kanai H, Aizaki M, Mitsui K, Araki Y, Kasama S, Iwasaki T, Ichikawa S. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. J Vasc Surg 2010;52:110-117.
4. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654.
5. Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 2015;61:2S-41S.
6. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr, Taylor LM. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-3049.
7. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989;3:273-277.
8. Peabody CN, Kannel WB, McNamara PM. Intermittent claudication. Surgical significance. Arch Surg 1974;109:693-697.
9. Ardati AK, Kaufman SR, Aronow HD, Nypaver TJ, Bove PG, Gurm HS, Grossman PM. The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions. Circ Cardiovasc Interv 2012;5:850-855.
10. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 2014;35:2864-2872.
11. Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta 1954;21:499-533.
12. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Karmody A, Whittemore AD, Baker JD, Ernst CB. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc committee on reporting standards, society for vascular surgery/North American chapter, International society for cardiovascular surgery. J Vasc Surg 1986;4:80-94.
13. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa S. 15-Year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv 2015;8:1893-1901.
14. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation 2012;126:2020-2035.
15. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992;18:433-440.
16. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003;107:753-756.
17. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardi disease: a statement from the American heart association councils on kidney in cardiovascular disease, High blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003;108:2154-2169.
18. Walsh CR, O'Donnell CJ, Camargo CA Jr., Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002;144:1003-1111.
19. Hojo Y, Kumakura H, Kanai H, Iwasaki T, Ichikawa S, Kurabayashi M. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease. Eur Heart J Cardiovasc Imaging 2016;17:492-497.
20. Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K. C-reactive protein predicts death in patients with previous premature myocardial infarction-a 10 year follow-up study. Atherosclerosis 2002;160:433-440.
21. Ishii H, Aoyama T, Takahashi H, Kamoi D, Tanaka M, Yoshikawa D, Hayashi M, Matsubara T, Murohara T. Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease. Atherosclerosis 2013;227:130-134.
22. Writing Committee M, Drozda JP, Jr., Ferguson TB, Jr., Jneid H, Krumholz HM, Nallamothu BK, Olin JW, Ting HH, Measures ACAFOP, Heidenreich PA, Albert NM, Chan PS, Curtis LH, Ferguson TB, Jr., Fonarow GC, Ho PM, O'Brien S, Russo AM, Thomas RJ, Ting HH, Varosy PD. 2015 ACC/AHA focused update of secondary prevention lipid performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes 2016;9:68-95.
23. Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM, Nissen SE. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 2010;55:2399-2407.
24. Antoniou GA, Fisher RK, Georgiadis GS, Antoniou SA, Torella F. Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis. Vascul Pharmacol 2014;63:79-87.
25. Ramos R, Garcia-Gil M, Comas-Cufi M, Quesada M, Marrugat J, Elosua R, Sala J, Grau M, Marti R, Ponjoan A, Alves-Cabratosa L, Blanch J, Bolibar B. Statins for prevention of cardiovascular events in a low-risk population with low ankle Brachial Index. J Am Coll Cardiol 2016;67:630-640.
26. Olin JW, White CJ, Armstrong EJ, Kadian-Dodov D, Hiatt WR. Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options. J Am Coll Cardiol 2016;67:1338-1357.
27. Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H, Ito T, Iwasaki T, Takayama Y, Ichikawa S, Fujita K, Nakashima K, Minami K. Sex-related differences in Japanese patients with peripheral arterial disease. Atherosclerosis 2011;219:846-850.
28. Armstrong EJ, Wu J, Singh GD, Dawson DL, Pevec WC, Amsterdam EA, Laird JR. Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. J Vasc Surg 2014;60:1565-1571.
29. Mills JL, Sr., Wixon CL, James DC, Devine J, Westerband A, Hughes JD. The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg 2001;33:273-278; discussion 278-280.
30. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR, Investigators IPST. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN. PACT SFA randomized trial. Circulation 2015;131:495-502.
31. Layden J, Michaels J, Bermingham S, Higgins B, Guideline Development G. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ 2012;345:e4947.
32. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009;53:1925-1932.